ASX:NANMedical Equipment
Nanosonics (ASX:NAN) Shares Grapple With Margin Squeeze Despite Trophon Strength
Nanosonics walked into this result with a stock that had been grinding lower, down about 22% over the past week and 11% over three months, and trading on a rich P/E of 47.4x. Today the sentiment test was simple: would investors still pay up for a premium multiple while net profit margins have slipped to 8.7% from 10.4% and revenue growth stayed modest for a medical equipment specialist?
The headline is clear: the market is wrestling with a margin squeeze story inside what is still pitched as...